Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Joe E. who wrote (2469)	10/24/1997 6:42:00 PM
From: BLUE HORSE SHOE	Respond to of 6136

The Immune Response Corp., Recently announced that data from a recently completed open-label trial of 15 patients which suggests that Remune induces the production of beta chemokines. This data demonstrates yet another advantage of Remune in protecting the patient from further HIV infection. Remember Remune is designed to be a possible compliment to the current antiviral drugs.

To: Joe E. who wrote (2469)	10/26/1997 11:30:00 AM
From: JOHN W.	Read Replies (1) \| Respond to of 6136

CHEMOKINES HAVE BEEN AROUND FOR OVER A DECADE Re: Dr. Gallo's Chemokines: Joe, I was told that AIDS researchers have been studying chemokines for over a decade? I am sure that Dr. Gallo's discovery of this new molecule is new, however, by his own admission, it will take several years before this strategy is even tested in Humans? So IF this new approach is proven effective in monkeys (2-3 yrs) and the in Humans (another 2-3 yrs) and then if approved (1-2 yrs) it may have an impact on current treatments. Also, since this treatment works in a completely different approach, it probably will be used in combination with combination therapy 6-8 yrs from now. This discovery poses not even a possibility of competition to Viracept for at 6-8 yrs. I doubt any misconception could be sincere enough to cause a "buying opportunity". If the mkt continues to freefall, this may create a huge opportunity again for informed investors and a escape for the shorts (our built in dedicated-buying support). My question is , how long have chemokines been around? I say over a decade.

To: Joe E. who wrote (2469)	10/27/1997 1:11:00 AM
From: George T. Santamaria	Read Replies (1) \| Respond to of 6136

Yeah, ever time a researcher comes up with a new discovery, it is touted as revolutionary and, in the next breath, the researcher claims that other contemporary developments are next to worthless. I saw this about two years ago as AGPH was wrapping up Ph II Viracept trials. At that time a researcher had presented a gene therapy approach for HIV and claimed that PI's were worthless because the HIV develops resistance. In the publish or perish academic environment, one has to have certain instincts in order to survive. The most crucial one is be naive enough to believe that every finding, every experiment is worthy of glory and publication.